Gothenburg, Sweden

Per L Lindberg

USPTO Granted Patents = 2 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Göteborg, SE (2019)
  • Gothenburg, SE (2021)

Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Per L Lindberg in Cancer Treatment

Introduction

Per L Lindberg is a noted inventor based in Gothenburg, Sweden, who has made significant contributions to cancer treatment. With two patents to his name, his work primarily focuses on enhancing chemotherapy effectiveness, specifically targeting colorectal cancer.

Latest Patents

Lindberg's recent innovations include two patents centered around the use of [6R]-5,10-methylenetetrahydrofolate (MTHF) as an adjuvant in chemotherapy. The first patent, titled "[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy," describes a method for administering this diastereomerically pure folate adjuvant within 5-fluorouracil (5-FU) based treatment regimens for solid tumors, including colorectal cancer (CRC). The second patent, "[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy," outlines a protocol for administering multiple boluses of [6R]-MTHF to improve treatment outcomes.

Career Highlights

Per L Lindberg works with Isofol Medical AB, a company dedicated to pioneering advances in oncology. His role has been pivotal in developing innovative treatment options that enhance the efficacy of existing chemotherapy therapies. Throughout his career, Lindberg has focused on research that bridges pharmacy and medical treatments, particularly in oncology.

Collaborations

Lindberg has collaborated with notable professionals in his field, including Anders Vedin and Gunnel E Sundén. These collaborations highlight the importance of teamwork in advancing medical innovations and ensuring the successful realization of complex patents.

Conclusion

Per L Lindberg stands out as a significant inventor within the realm of cancer research and treatment. His innovative patents focusing on the use of [6R]-MTHF in chemotherapy mark essential advancements in the fight against colorectal cancer, showcasing the potential of improved therapeutics in oncology. As cancer treatment continues to evolve, the contributions of innovators like Lindberg are vital for establishing more effective and targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…